The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Facial Acne Vulgaris.

Abstract

BACKGROUND:

Azelaic acid demonstrates anti-inflammatory, anti-oxidative, anti-comedogenic, and anti-microbial effects. Azelaic acid 20% cream is currently approved for the treatment of acne vulgaris, and azelaic acid 15% foam has recently been approved for rosacea. Given the favorable tolerability profile of foam preparations, it is reasonable to assume that azelaic acid 15% foam could serve as a viable treatment option for facial acne.

OBJECTIVE:

To examine the efficacy and safety of azelaic acid 15% foam in the treatment of moderate-to-severe facial acne Methods: Twenty subjects with moderate-to-severe facial acne vulgaris were enrolled in this two-center, open-label pilot study. All study subjects were treated with azelaic acid 15% foam for 16 weeks. Efficacy analyses were based on the change in facial investigator global assessment (FIGA) and changes in total, inflammatory, non-inflammatory lesion counts between baseline and week 16.

RESULTS:

There was a significant reduction in FIGA scores from baseline to week 16 (p = .0004), with 84% of subjects experiencing at least a 1 grade improvement, and 63% of subjects achieving a final grade of Clear or Almost Clear. All subjects experienced reductions in inflammatory and total lesion counts by week 16, and 89% of subjects experienced reductions in non-inflammatory lesions. Azelaic acid 15% foam was well tolerated, with almost all instances of erythema, dryness, peeling, oiliness, pruritus, and burning being of mild or trace degree, and most adverse effects resolving by the end of the study.

CONCLUSION:

Azelaic acid 15% foam is effective and safe in the treatment of facial acne vulgaris. Given the convenience of foam vehicles, azelaic acid 15% foam should be considered as a viable treatment option for this condition. J Drugs Dermatol. 2018;17(6):641-645.

• Authors: Peter W Hashim, Tinley Chen, Julie C Harper, Leon H Kircik
• Journal: Journal of drugs in dermatology : JDD (J Drugs Dermatol) Vol. 17 Issue 6 Pg. 641-645 (Jun 01 2018) ISSN: 1545-9616 [Print] United States
• PMID: 29879251 (Publication Type: Journal Article, Multicenter Study)

Chemical References

• Dicarboxylic Acids
• azelaic acid

Topics

• Acne Vulgaris (diagnosis, drug therapy)
• Administration, Topical
• Adolescent
• Adult
• Dermatitis (diagnosis, etiology)
• Dicarboxylic Acids (administration & dosage, adverse effects, chemistry)
• Drug Compounding
• Erythema (chemically induced, diagnosis)
• Face
• Female
• Humans
• Pilot Projects
• Treatment Outcome
• Young Adult